Megan Sniecinski, Chief Business Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 45,000 shares at $1.45 ($65K) on 2019-11-18, disclosed to the SEC on 2019-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.